These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
204 related articles for article (PubMed ID: 38400605)
1. Three exonic variants in the COL4A5 gene alter RNA splicing in a minigene assay. Zhang R; Lang Y; Shi X; Zhang Y; Liu X; Pan F; Qiao D; Teng X; Shao L Mol Genet Genomic Med; 2024 Feb; 12(2):e2395. PubMed ID: 38400605 [TBL] [Abstract][Full Text] [Related]
2. Aberrant splicing caused by exonic single nucleotide variants positioned 2nd or 3rd to the last nucleotide in the COL4A5 gene. Okada E; Aoto Y; Horinouchi T; Yamamura T; Ichikawa Y; Tanaka Y; Ueda C; Kitakado H; Kondo A; Sakakibara N; Suzuki R; Usui J; Yamagata K; Iijima K; Nozu K Clin Exp Nephrol; 2023 Mar; 27(3):218-226. PubMed ID: 36371577 [TBL] [Abstract][Full Text] [Related]
3. Functional assessment of a novel COL4A5 splice region variant and immunostaining of plucked hair follicles as an alternative method of diagnosis in X-linked Alport syndrome. Malone AF; Funk SD; Alhamad T; Miner JH Pediatr Nephrol; 2017 Jun; 32(6):997-1003. PubMed ID: 28013382 [TBL] [Abstract][Full Text] [Related]
7. Comparative Functional Analysis in vitro of 2 COL4A5 Splicing Mutations at the Same Site in 2 Unrelated Alport Syndrome Chinese Families. Lv X; Wu WQ; Zhang JX; Miao LF; Yu BZ; Chen FF; Cui YX; Xia ZK; Liu ZH; Li XJ Cytogenet Genome Res; 2020; 160(5):238-244. PubMed ID: 32659759 [TBL] [Abstract][Full Text] [Related]
8. Determination of the pathogenicity of known COL4A5 intronic variants by in vitro splicing assay. Horinouchi T; Nozu K; Yamamura T; Minamikawa S; Nagano C; Sakakibara N; Nakanishi K; Shima Y; Morisada N; Ishiko S; Aoto Y; Nagase H; Takeda H; Rossanti R; Kaito H; Matsuo M; Iijima K Sci Rep; 2019 Sep; 9(1):12696. PubMed ID: 31481700 [TBL] [Abstract][Full Text] [Related]
9. Six Exonic Variants in the Wang S; Wang Y; Wang J; Liu Z; Zhang R; Shi X; Han Y; Guo W; Bottillo I; Shao L Front Genet; 2020; 11():585064. PubMed ID: 33250922 [TBL] [Abstract][Full Text] [Related]
10. X-linked Alport syndrome caused by splicing mutations in COL4A5. Nozu K; Vorechovsky I; Kaito H; Fu XJ; Nakanishi K; Hashimura Y; Hashimoto F; Kamei K; Ito S; Kaku Y; Imasawa T; Ushijima K; Shimizu J; Makita Y; Konomoto T; Yoshikawa N; Iijima K Clin J Am Soc Nephrol; 2014 Nov; 9(11):1958-64. PubMed ID: 25183659 [TBL] [Abstract][Full Text] [Related]
11. Genetic and molecular dynamics analysis of two variants of the COL4A5 gene causing Alport syndrome. Liang L; Wu H; Cai Z; Zhao J BMC Med Genomics; 2023 Aug; 16(1):192. PubMed ID: 37596645 [TBL] [Abstract][Full Text] [Related]
12. Minigene splicing assays reveal new insights into exonic variants of the SLC12A3 gene in Gitelman syndrome. Shi X; Wang H; Zhang R; Liu Z; Guo W; Wang S; Liu X; Lang Y; Bottillo I; Dong B; Shao L Mol Genet Genomic Med; 2023 Apr; 11(4):e2128. PubMed ID: 36597580 [TBL] [Abstract][Full Text] [Related]
13. A wave of deep intronic mutations in X-linked Alport syndrome. Boisson M; Arrondel C; Cagnard N; Morinière V; Arkoub ZA; Saei H; Heidet L; Kachmar J; Hummel A; Knebelmann B; Bonnet-Dupeyron MN; Isidor B; Izzedine H; Legrand E; Couarch P; Gribouval O; Bole-Feysot C; Parisot M; Nitschké P; Antignac C; Dorval G Kidney Int; 2023 Aug; 104(2):367-377. PubMed ID: 37230224 [TBL] [Abstract][Full Text] [Related]
14. X-linked Alport syndrome associated with a synonymous p.Gly292Gly mutation alters the splicing donor site of the type IV collagen alpha chain 5 gene. Fu XJ; Nozu K; Eguchi A; Nozu Y; Morisada N; Shono A; Taniguchi-Ikeda M; Shima Y; Nakanishi K; Vorechovsky I; Iijima K Clin Exp Nephrol; 2016 Oct; 20(5):699-702. PubMed ID: 26581810 [TBL] [Abstract][Full Text] [Related]
15. Twelve exonic variants in the Xin Q; Liu Q; Liu Z; Shi X; Liu X; Zhang R; Hong Y; Zhao X; Shao L Front Genet; 2022; 13():961384. PubMed ID: 36092934 [No Abstract] [Full Text] [Related]
16. Defective pre-mRNA splicing in PKD1 due to presumed missense and synonymous mutations causing autosomal dominant polycystic disease. Gonzalez-Paredes FJ; Ramos-Trujillo E; Claverie-Martin F Gene; 2014 Aug; 546(2):243-9. PubMed ID: 24907393 [TBL] [Abstract][Full Text] [Related]
17. The Contribution of Yamamura T; Horinouchi T; Aoto Y; Lennon R; Nozu K Front Med (Lausanne); 2022; 9():841391. PubMed ID: 35211492 [TBL] [Abstract][Full Text] [Related]
18. The NM_033380.2 transcript of the Liang L; Wu H; Zhao J Front Genet; 2024; 15():1330525. PubMed ID: 38818038 [TBL] [Abstract][Full Text] [Related]
19. X-Linked and Autosomal Recessive Alport Syndrome: Pathogenic Variant Features and Further Genotype-Phenotype Correlations. Savige J; Storey H; Il Cheong H; Gyung Kang H; Park E; Hilbert P; Persikov A; Torres-Fernandez C; Ars E; Torra R; Hertz JM; Thomassen M; Shagam L; Wang D; Wang Y; Flinter F; Nagel M PLoS One; 2016; 11(9):e0161802. PubMed ID: 27627812 [TBL] [Abstract][Full Text] [Related]
20. Effect of heterozygous pathogenic COL4A3 or COL4A4 variants on patients with X-linked Alport syndrome. Zhang Y; Ding J; Zhang H; Yao Y; Xiao H; Wang S; Wang F Mol Genet Genomic Med; 2019 May; 7(5):e647. PubMed ID: 30883042 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]